ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Up 40.8% in January

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 10,000 shares, a growth of 40.8% from the January 15th total of 7,100 shares. Based on an average daily volume of 347,300 shares, the short-interest ratio is currently 0.0 days.

ProtoKinetix Stock Up 6.8 %

OTCMKTS PKTX traded up $0.00 during trading hours on Friday, hitting $0.01. 949,666 shares of the company’s stock traded hands, compared to its average volume of 168,530. ProtoKinetix has a 52-week low of $0.01 and a 52-week high of $0.02. The firm’s 50-day moving average is $0.01 and its 200-day moving average is $0.01.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.